Top Institutions in Ophthalmology - Retina
Leading institutions in this area are recognized for their pioneering clinical trials in retinal gene therapies, extensive research in diabetic retinopathy pathophysiology, and development of novel anti-VEGF delivery methods including suprachoroidal injections. Their expertise includes conducting multi-year phase 2 and 3 clinical trials, translational research in ocular gene therapy, and retina subspecialty clinical care.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and gene therapy clinical trials, with extensive experience in diabetic retinopathy and anti-VEGF treatment innovations.
Key Differentiators
- Ophthalmology
- Retina
- Gene Therapy
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is renowned for its clinical research in diabetic retinopathy and innovative retinal therapies, including anti-VEGF treatments and gene therapy trials.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye has a strong retina subspecialty program with a focus on diabetic retinopathy and emerging gene therapies, contributing significant clinical trial data in anti-VEGF treatments.
Key Differentiators
- Ophthalmology
- Retina
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in ocular gene therapy research and clinical trials, with a strong focus on retinal diseases including diabetic retinopathy and innovative anti-VEGF delivery systems.
Key Differentiators
- Ophthalmology
- Retina
- Gene Therapy
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







